CARDIOVASCULAR MORTALITY IN 12 RUSSIAN FEDERATION REGIONS – PARTICIPANTS OF THE “CARDIOVASCULAR DISEASE EPIDEMIOLOGY IN RUSSIAN REGIONS” STUDY by S. A. Shalnova, A. O. Konradi, Yu. A. Karpov, A. V. Kontsevaya, A. D. Deev, A. V. Kapustina, M. B. Khudyakov, E. V. Shlyakhto, S. A. Boytsov

Subjects: Get full text

Comments on the section “Cardiovascular risk estimation” in the 2021 European Society of Cardiology guidelines on cardiovascular disease prevention in clinical practice by S. A. Shalnova

“…The article discusses a new approach to assessing cardiovascular risk in clinical practice, presented in the European guidelines 2021. …”
Get full text

Factors influencing cardiovascular mortality in Russian population by S. A. Shalnova, A. D. Deev, R. G. Oganov

“…According to the results of prospective studies performed at the State Research Center for Preventive Medicine, the data on main cardiovascular risk factors prevalence, their role in total cardiovascular mortality, coronary heart disease and stroke mortality in Russian population are presented. …”
Get full text

Outline of the Project Recommendations on renal function assessment in patients with cardiovascular disease or elevated cardiovascular risk.... by V. S. Moiseev, N. A. Mukhin, Zh. D. Kobalava, S. V. Villevalde, M. A. Efremovtseva, L. V. Kozlovskaya, Yu. V. Kotovskaya, V. V. Fomin, S. A. Shalnova

Get full text

CARDIOVASCULAR HEALTH EVALUATION: FORMER FACTORS — NOVEL MODEL by A. E. Imaeva, S. A. Shalnova

“…Cardiovascular diseases (CVD) play leading roles among the main causes of death around the globe. …”
Get full text

Cardiovascular health monitoring of the Russian population: practical implications by S. A. Shalnova

Get full text

Atherogenic index of plasma as an additional marker of adverse cardiovascular outcomes by Yu. I. Grinshtein, V. V. Shabalin, R. R. Ruf, S. A. Shalnova, O. M. Drapkina

“…The study included a random representative sample of 1603 residents of the Krasnoyarsk and Berezovsky rural district aged 25-64 years as part of the Epidemiology of Cardiovascular Diseases and their Risk Factors in Regions of Russian Federation (ESSE-RF) study. …”
Get full text

COMMENTS ON EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE by S. A. Shalnova

Get full text

BODY WEIGHT AND ITS IMPACT ON ALL-CAUSE AND CARDIOVASCULAR MORTALITY IN RUSSIA by S. A. Shalnova, A. D. Deev, A. V. Kapustina, Yu. A. Balanova, V. V. Konstantinov, N. V. Kiseleva

Get full text

Assessment of all-cause and cardiovascular death risk in Russian men with leg pain by S. A. Shalnova, E. B. Yarovaya, V. A. Kutsenko, A. V. Kapustina, Yu. K. Makarova, Yu. A. Balanova, A. E. Imaeva, G. A. Muromtseva, O. M. Drapkina

“…To study the prevalence of intermittent claudication (IC) and assess the risk of cardiovascular and all-cause death In Russian men with IC according to 30-year follow-up.Material and methods. …”
Get full text

Prevalence of factors affecting prognosis in arterial hypertension, and total cardiovascular risk assessment by T. N. Timofeeva, S. A. Shalnova, V. V. Konstantinov, V. M. Ivanov, A. V. Kapustina, Yu. A. Balanova, I. N. Lelchuk, A. D. Deev

“…To study prevalence of risk factors (RF), target organ damage (TOD), and associated clinical conditions (ACC) in arterial hypertension (AH) patients, for total cardiovascular risk assessment. Material and methods. …”
Get full text

PROLOG Study: decreasing cardiovascular disease risk in hypertensive patients by antihypertensive therapy by S. A. Shalnova, S. Yu. Martsevich, A. D. Deev, N. P. Kutishenko, R. G. Oganov

“…PROLOG results demonstrated cardiovascular risk reduction for both groups, but in IG it was greater by 50% than in CG.…”
Get full text

Association of Conventional Cardiovascular Risk Factors with Carotid Atherosclerosis Prevalence in General Population by V. S. Kaveshnikov, V. N. Serebryakova, I. A. Trubacheva, S. A. Shalnova

Get full text

ASSOCIATION OF GLUCOSE WITH GENERAL AND CARDIOVASCULAR MORTALITY AMONG POPULATION FROM 55 YEARS AND OLDER by A. E. Imaeva, A. V. Kapustina, D. A. Smirnov, Yu. A. Balanova, G. A. Muromtseva, A. D. Deev, S. A. Shalnova, M. A. Shkolnikova, V. M. Shkolnikov

Subjects: Get full text

The Trends of Cardiovascular and Cancer Mortality in Russian Men and Women from 2000 to 2016 years by S. A. Shalnova, O. M. Drapkina

Subjects: “…cardiovascular diseases…”
Get full text

Prevalence of carbohydrate metabolism disorders and association with cardiovascular diseases in a large Siberian region by V. V. Shabalin, Yu. I. Grinshtein, R. R. Ruf, I. V. Filonenko, S. A. Shalnova, O. M. Drapkina

Subjects: Get full text

Pilot project to study the association of troponin I with cardiovascular events in the population of Russian region by S. A. Shalnova, O. M. Drapkina, A. V. Kontsevaya, E. B. Yarovaya, V. A. Kutsenko, V. A. Metelskaya, A. V. Kapustina, Yu. A. Balanova, O. A. Litinskaya, M. S. Pokrovskaya

“…The endpoints were hard (cardiovascular death and myocardial infarction) and composite endpoints (cardiovascular death, new cases of myocardial infarction, stroke, coronary artery disease and revascularization). …”
Get full text

POPULATION MODELS OF CARDIOVASCULAR RISK PREDICTION: EXPEDIENCE OF MODELING AND ANALYTIC REVIEW OF CURRENT MODELS by A. V. Kontsevaya, S. A. Shalnova

“…The review collects the data on the approaches to modeling of population risk of cardiovascular diseases (CVD), including methodological aspects and practical significance of modeling results. …”
Get full text

TOBACCO DEPENDENCE TREATMENT WITH NICOTINE REPLACEMENT THERAPY AS ONE OF THE METHODS FOR CARDIOVASCULAR DISEASE RISK REDUCTION by O. V. Vikhireva, S. A. Shalnova, A. D. Deev

Subjects: Get full text

Atorvastatin effectiveness and safety in patients with high cardiovascular risk. Revising the results of the OSCAR Study (2006) by S. A. Shalnova, A. D. Deev, N. V. Kiseleva

“…To investigate the effects of a atorvastatin (Atoris, KRKA) on major clinical parameters in patients with high cardiovascular risk – the participants of the OSCAR Study (2006). …”
Get full text